Compound Evidence File
#EC-2026-0064
GHRP-2 Acetate
Filed under Peptides. The bureau holds 185 laboratory returns for this compound from 83 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
83 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Nov 2025 | 27 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 10.0 | 10.0 | 9 Jan 2026 | 4 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 10.0 | 10.0 | 10 Mar 2026 | 12 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 23 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Dec 2025 | 17 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 20 Nov 2025 | 13 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Apr 2026 | 8 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 10.0 | 10.0 | 23 Nov 2025 | 8 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Dec 2025 | 8 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Feb 2026 | 8 Aug 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Jun 2026 | 10 Jul 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 | 11 Jun 2025 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 10.0 | 10.0 | 10.0 | 8 Jul 2025 | 8 Jul 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 10.0 | 10.0 | 10.0 | 7 May 2025 | 7 May 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 | 13 Jun 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Feb 2026 | 6 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Mar 2026 | 11 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Jun 2026 | 15 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 17 Jan 2026 | 10 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Mar 2026 | 7 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 24 Dec 2025 | 10 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Jun 2026 | 22 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 11 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 1 Feb 2026 | 15 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Jan 2026 | 17 Jul 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.6 | 9.2 | 10.0 | 21 May 2026 | 21 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 9.1 | 9.1 | 9.1 | 2 Jul 2025 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 9.0 | 7.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| CellupepCASE #VI-2026-0888 | X | 1 | 9.0 | 9.0 | 9.0 | 9 Jun 2025 | 9 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.9 | 7.9 | 9.6 | 24 May 2026 | 24 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 1 | 8.8 | 8.8 | 8.8 | 24 Apr 2025 | 24 Apr 2025 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 | 16 Mar 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.6 | 8.0 | 9.1 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.6 | 7.6 | 10.0 | 25 May 2026 | 25 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 8.5 | 8.5 | 8.5 | 13 Feb 2025 | 13 Feb 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 2 | 8.3 | 7.2 | 9.4 | 13 Jun 2025 | 19 Jan 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 8.3 | 7.3 | 9.3 | 3 Jun 2025 | 24 May 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 | 28 Mar 2025 |
| Skye PeptidesCASE #VI-2026-0451 | X | 1 | 8.1 | 8.1 | 8.1 | 7 May 2025 | 7 May 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 2 | 7.9 | 6.9 | 8.8 | 25 Apr 2025 | 21 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 5 | 7.7 | 6.0 | 9.8 | 16 Mar 2025 | 21 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 7.7 | 7.3 | 8.0 | 14 Jan 2025 | 19 Jan 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 3 | 7.5 | 7.3 | 7.7 | 13 Jun 2025 | 25 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 6 | 7.4 | 5.5 | 9.5 | 27 Feb 2025 | 25 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 7.2 | 6.5 | 7.8 | 20 Jun 2025 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 7.2 | 7.2 | 7.2 | 27 Feb 2025 | 27 Feb 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 | 24 Apr 2025 |
| UtherCASE #VI-2026-0902 | X | 6 | 7.0 | 5.6 | 10.0 | 2 Jul 2025 | 20 May 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 | 25 Apr 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 | 6 May 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.5 | 6.5 | 6.5 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 6.4 | 6.1 | 6.7 | 20 Jun 2025 | 25 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 | 28 Mar 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.4 | 6.4 | 6.4 | 2 Apr 2025 | 2 Apr 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 | 3 Jul 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 6.2 | 5.1 | 7.4 | 9 Jun 2025 | 20 May 2026 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 | 28 Mar 2025 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 6.1 | 6.1 | 6.1 | 16 Mar 2025 | 16 Mar 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 6.0 | 6.0 | 6.0 | 21 May 2025 | 21 May 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 5.9 | 5.1 | 6.8 | 20 Jun 2025 | 19 Jan 2026 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 5.7 | 5.7 | 5.7 | 14 Jan 2025 | 14 Jan 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.6 | 5.6 | 5.6 | 7 May 2025 | 7 May 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 5.6 | 5.6 | 5.6 | 28 Mar 2025 | 28 Mar 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 | 13 Feb 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 | 3 Jul 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 3 | 5.4 | 4.3 | 6.5 | 3 Jul 2025 | 19 Jan 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 5.4 | 5.4 | 5.4 | 9 Jun 2025 | 9 Jun 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 1 | 5.2 | 5.2 | 5.2 | 17 Dec 2024 | 17 Dec 2024 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 4.9 | 4.9 | 4.9 | 13 Feb 2025 | 13 Feb 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 3.9 | 3.9 | 3.9 | 6 May 2025 | 6 May 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 3 | 3.8 | 2.8 | 4.8 | 28 Mar 2025 | 24 May 2026 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 3.7 | 3.7 | 3.7 | 9 Jun 2025 | 9 Jun 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 3.2 | 3.2 | 3.2 | 28 Mar 2025 | 28 Mar 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.3 | 2.3 | 2.3 | 3 Jun 2025 | 3 Jun 2025 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 1.9 | 1.4 | 2.4 | 25 Apr 2025 | 17 May 2026 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 1.8 | 1.8 | 1.8 | 14 Jan 2025 | 14 Jan 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 1.6 | 1.6 | 1.6 | 2 Apr 2025 | 2 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.6 | 0.6 | 0.6 | 2 Jul 2025 | 2 Jul 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.5 | 0.5 | 0.5 | 8 Jul 2025 | 8 Jul 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for GHRP-2 Acetate alone.